Evidence map›Paper›PMID 32260417›Full record

ArticleMaterials (Basel, Switzerland)2020

In Vitro Generation of Novel Functionalized Biomaterials for Use in Oral and Dental Regenerative Medicine Applications. Running Title: Fibrin-Agarose Functionalized Scaffolds.

Cristina Blanco-Elices, Enrique España-Guerrero, Miguel Mateu-Sanz, David Sánchez-Porras, Óscar Darío García-García, María Del Carmen Sánchez-Quevedo, Ricardo Fernández-Valadés, Miguel Alaminos, Miguel Ángel Martín-Piedra, Ingrid Garzón

Erratum issuedAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Cristina Blanco-ElicesDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.
Enrique España-GuerreroPrograma de doctorado Medicina Clínica y Salud Pública, University of Granada, 18071 Granada, Spain.
Miguel Mateu-SanzDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.ORCID 0000-0001-5117-6071
David Sánchez-PorrasDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.ORCID 0000-0002-4755-7741
Óscar Darío García-GarcíaDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.
María Del Carmen Sánchez-QuevedoDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.
Ricardo Fernández-ValadésDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.
Miguel AlaminosDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.ORCID 0000-0003-4876-2672
Miguel Ángel Martín-PiedraDepartment of Histology (Tissue Engineering Group), University of Granada, 18071 Granada, Spain.
Ingrid GarzónDepartment of Histology, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, E18016, 18071 Granada, Granada, Spain.

Funding

Instituto de Salud Carlos III FIS PI18/331Instituto de Salud Carlos III PI18/332Plan propio, Universidad de Granada and Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucia (Co-financed by European Regional Development Fund - FEDER) Grant PSETC_19_001 from
6 · The paper itself

Abstract

Recent advances in tissue engineering offer innovative clinical alternatives in dentistry and regenerative medicine. Tissue engineering combines human cells with compatible biomaterials to induce tissue regeneration. Shortening the fabrication time of biomaterials used in tissue engineering will contribute to treatment improvement, and biomaterial functionalization can be exploited to enhance scaffold properties. In this work, we have tested an alternative biofabrication method by directly including human oral mucosa tissue explants within the biomaterial for the generation of human bioengineered mouth and dental tissues for use in tissue engineering. To achieve this, acellular fibrin-agarose scaffolds (AFAS), non-functionalized fibrin-agarose oral mucosa stroma substitutes (n-FAOM), and novel functionalized fibrin-agarose oral mucosa stroma substitutes (F-FAOM) were developed and analyzed after 1, 2, and 3 weeks of in vitro development to determine extracellular matrix components as compared to native oral mucosa controls by using histochemistry and immunohistochemistry. Results demonstrate that functionalization speeds up the biofabrication method and contributes to improve the biomimetic characteristics of the scaffold in terms of extracellular matrix components and reduce the time required for in vitro tissue development.

Indexed as

biomaterialsextracellular matrixfunctionalizationoral and dental tissuestissue engineering

Identifiers

PMID32260417
PMCPMC7178710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.